Is telemedicine the future of joint health and GI care?
Hinge Health’s CEO talks about founding the company and the recent Cylinder acquisition.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
Hinge Health’s CEO talks about founding the company and the recent Cylinder acquisition.
The year has come with a lot of challenges, from a tough economic environment to a rise in uninsured patients.
The tech giant’s VP of health told us how the company goes about designing new features.
The move may be a sign that Big Pharma companies are becoming more comfortable with the once-stigmatized field.
That could lead to downstream consequences for medical research, one expert says.
And more could shutter their obstetric units in the face of Medicaid cuts.
The two pharma giants are in competition for dominance in the obesity and diabetes markets.
Increased access to naloxone and harm reduction supplies have made an impact, according to a recent analysis.
The largest percentage is non-melanoma skin cancer, according to federal data.
Longer wait times could lead to worse health outcomes.